Pour plus d’informations, veuillez nous contacter.
Références
Appelbaum PS. Clinical practice. Assessment of patients' competence to consent to treatment. N Engl J Med. 2007; 357(18):1834-40.
Appelbaum PS, Grisso T. Assessing patients' capacities to consent to treatment. N Engl J Med. 1988 Dec 22;319(25):1635-8.
Bremault-Phillips SC, Parmar J, Friesen S, Rogers LG, Pike A, Sluggett B. An Evaluation of the Decision-Making Capacity Assessment Model. Can Geriatr J. 2016;19(3):83-96.
Code civil du Québec, RLRQ c CCQ-1991 [online]. Available at: http://canlii.ca/t/6b48h.
Charte des droits et libertés de la personne [online]. Available at: http://legisquebec.gouv.qc.ca/fr/showdoc/cs/C-12.
Collège des médecins. Le médecin et le consentement aux soins - Document de référence 09/2018 [online]. Available at: http://www.cmq.org/publications-pdf/p-1-2018-09-11-fr-medecin-consentement-aux-soins.pdf.
Demakis, GJ. Civil capacities in clinical neuropsychology : Research Findings and Practical Applications. Oxford University Press, 2012.
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
Gauthier L. Guide de pratique. L'évaluation psychosociale dans le contexte des régimes de protection, du mandat donné en prévision de l'inaptitude et des autres mesures de protection au majeur. 2011.
Geneau, D. Évaluation clinique de l'aptitude de la personne âgée. Objectif prévention 2005; 28:1-2.
Giroux D. L'évaluation de l'aptitude à gérer ses biens et sa personne chez une clientèle âgée atteinte de déficits cognitifs. Un outil d'évaluation. Québec, Canada: Université Laval, 2011.
Grisso T. Evaluating Competencies - Forensic Assessments and Instruments | Thomas Grisso | Springer: Springer US, 2003.
Grisso T, Appelbaum PS, Hill-Fotouhi C. The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions. Psychiatr Serv. 1997;48(11):1415-1419.
Grisso T & Appelbaum PS. Assessing competence to consent to treatment. A guide for physicians and other health professionals. New York: Oxford University Press 1998.
IUSMQ CdQ. Examen de l'état mental [online]. Available at: https://www.aqiism.org/wp-content/uploads/2015/05/Examen_etat_mental_Definition_termes.pdf.
Jenkinson PM, Fotopoulou A. Understanding Babinski's anosognosia: 100 years later. Cortex. 2014;61:1-4.
Larouche E, Tremblay MP, Potvin O, et al. Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People. Arch Clin Neuropsychol 2016.
Liptzin B, Peisah C, Shulman K, Finkel S, International Psychogeriatric Association Task Force on T. Testamentary capacity and delirium. Int Psychogeriatr. 2010;22(6):950-956.
Long D, Robert AM. L'évaluation en psychogériatrie de l'aptidue à administrer ses biens, à prendre soin de sa personne et à consentir aux soins. Revue québécoise de psychologie. 1996: 17(2).
Mills WL, Regev T, Kunik ME, et al. Making and Executing Decisions for Safe and Independent Living (MED-SAIL): development and validation of a brief screening tool. Am J Geriatr Psychiatry. 2014;22(3):285-293.
Moye J, Karel MJ, Gurrera RJ, Azar AR. Neuropsychological predictors of decision-making capacity over 9 months in mild-to-moderate dementia. J Gen Intern Med. 2006;21(1):78-83.
Moye J, Marson DC. Assessment of decision-making capacity in older adults: an emerging area of practice and research. J Gerontol B Psychol Sci Soc Sci. 2007; 62: P3-P11.
Naik AD, Lai JM, Kunik ME, Dyer CB. Assessing capacity in suspected cases of self-neglect. Geriatrics. 2008;63(2):24-31.
Naik AD, Pickens S, Burnett J, Lai JM, Dyer CB. Assessing capacity in the setting of self-neglect: development of a novel screening tool for decision-making capacity. J Elder Abuse Negl. 2006;18(4):79-91.
Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
Parmar J, Bremault-Phillips S, Charles L. The development and implementation of a decision-making capacity assessment model. Can Geriatr J. 2015;18(1):15-28.
Parrao T, Brockman S, Bucks RS, et al. The Structured Interview for Insight and Judgment in Dementia: Development and validation of a new instrument to assess awareness in patients with dementia. Alzheimers Dement (Amst). 2017;7:24-32.
Peisah C, Luxenberg J, Liptzin B, Wand AP, Shulman K, Finkel S. Deathbed wills: assessing testamentary capacity in the dying patient. Int Psychogeriatr. 2014;26(2):209-216.
Prigatano GP. Anosognosia and patterns of impaired self-awareness observed in clinical practice. Cortex. 2014;61:81-92.
Proulx S. Carrier H. Psychiatrie légale – droit Civil. In: Lalonde P, Pinard G. Psychiatrie Clinique. Média Livre Inc. 4ème édition. 2016: 1167-1186.
Québec Cpd. Évaluation médicale dans le cadre d'une demande d'ouverture d'un régime de protection ou de l'homologation d'un mandat.Québec Cpd. Aptitude et consentement aux soins [online]. Available at: https://www.curateur.gouv.qc.ca/cura/publications/reseau_de_la_sante/mod03.pdf.
Silberfeld M, Nash C, Singer PA. Capacity to complete an advance directive. J Am Geriatr Soc. 1993;41(10):1141-1143.
Silberfeld M. Legal standards and the shershold of competence. Adv Q 1993 ; 14: 482-487.
Institut national d'excellence en santé et en services sociaux. L'échelle MMSE. Échelle de statut mental [online]. Available at: http://inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Geriatrie/INESSS_FicheOutil_Echelle_MMSE.pdf.
Shulman et al. Contemporaneous assessment of testamentary capacity. International Psychogeriatrics 2009; 21:433-439.
Stancliffe RJ, Abery BH, Springborg H, Elkin S. Substitute decision-making and personal control: implications for self-determination. Ment Retard 2000;38:407-421.
Voskou P, Douzenis A, Economou A, Papageorgiou SG. Testamentary Capacity Assessment: Legal, Medical, and Neuropsychological Issues. J Geriatr Psychiatry Neurol. 2018; 31(1): 3-12.
CLINICAL AND EDUCATIONAL USE
Universities/Foundations/Health Professionals/Hospitals/Clinics/Public Health Institutes:
GEMA© may be used, reproduced, and distributed WITHOUT permission. The test should be made available free of charge to patients. Written permission and Licensing Agreement is required if funded by commercial entity or pharma. To request permission, please fill out the form below.
Commercial Entity/Pharma :
GEMA© may be used, reproduced, and distributed, WITH prior written permission and Licensing Agreement. The test should be made available free of charge to patients. To request permission, please fill out the form below.
RESEARCH USE
Universities/Foundations/Health Professionals/Hospitals/Clinics/Public Health Institutes :
GEMA© may be used, reproduced, and distributed WITH permission.
The test should be made available free of charge to patients.
Written permission and Licensing Agreement is required if funded by commercial entity or pharma.
To request permission, please fill out the form below.
Commercial Entity/Pharma:
GEMA© may be used, reproduced, and distributed, WITH prior written permission and Licensing Agreement.
The test should be made available free of charge to patients.
PUBLICATIONS
If you would like to print the GEMA© in a book or in another source, please request permission to do so by using the SEND US A MESSAGE form in the CONTACT page, indicating the title of your publication.
It is prohibited to publish the GEMA© test and/or instructions and/or a link leading to these in newspaper and magazine articles (including electronic articles). The GEMA© is intended for healthcare professionals.
WEB USE
The GEMA© test and instructions are only to be accessed through the GEMA© website (www.testgema.com). It is therefore prohibited to post the GEMA© test and/or instructions on a website.
DÉVELOPMENT
The GEMA© is copyrighted. The development of material related to the GEMA©, including the development of an electronic version of the GEMA© or any other electronic material, is prohibited.